The Diagnostics-to-Product Pipeline: How AI Skin Analysis Apps are Fueling Hyper-Personalized Skincare
Key Takeaways: The skincare segment is witnessing a rapid shift towards data-driven diagnostics from mere subjective self-evaluation. The product pipelines are changing in the AI era, as now developing products on the basis of customers’ concerns has become obsolete. AI-equipped applications are serving as a diagnostic front-end tool that powers a seamless pipeline from skin […]
Technology Feasibility Assessment for Viral Nervous Necrosis Prevention and Management
A leading biotechnology firm engaged Stellarix for competitive benchmarking and technology feasibility assessment. Our strategic insights helped the client accelerate market readiness by identifying gaps and pinpointing scalable innovations in aquaculture, specifically supporting the development of commercial vaccines for VNN (Viral Nervous Necrosis). Client Background: A Global life sciences and biotechnology conglomerate specializing in sustainable […]
Fibermaxxing: From Wellness Trend to F&B Industry Shift
Key Takeaways: What’s Next after Proteins and Who Will Benefit the Most from It? Research shows that the next trend in the Food and Beverage industry will be Fibermaxxing. Fibermaxxing is a Gen Z social media term that represents maximizing fiber consumption by meeting or exceeding the recommended daily intake of fiber. The concept of […]
Next-Gen Heat Exchangers: How Additive Manufacturing and Nanocoatings are Revolutionizing Heat Transfer
Key Takeaways: The Thermal Wall: Why Incremental Innovation is no Longer an Option For decades, thermal management was solved as a commodity problem. As we enter into the era of AI-factories, the traditional approach has hit the Thermal Wall. Traditional designs of heat exchangers are not just bulky; they are becoming a liability for the […]
Beyond the Molecule: Agrochemicals Reimagined
How is Agility Underlining the New Era of Agrochemicals? The 2026 agrochemical outlook is way more than a projection exercise; it is a reflection of the pressures that are restructuring portfolios, channels, and innovation pipelines. Regulatory attrition across Europe is removing molecules faster than innovation pipelines. Another contributor is climate change, which is reorganizing pest-disease […]
How Startup Disruption is Reshaping the Agrochemicals Industry from Compliance to Crossroads?
Key Takeaways: The agrochemical industry is no longer debating the pace of transition from synthetic pesticides; it has embraced the change. The focus is now on realigning operations with emerging parameters and expectations of various stakeholders of this value chain. As per Stellarix’s observation, the global crop protection market is valued at approximately $85.6 billion. […]
2026 Agrochemicals Industry Outlook
Agrochemicals are going through a structural evolution. The shift is not something that reflects in a few product launches or initial revenues, but much slower, hard-to-reverse changes that are rewiring the entire industry. The manufacturers are finally moving ahead of the conventional sell more volume, expand acreage coverage, and defend market share approach. As the […]
FRESH Act 2026: Decoding the Tale of Two Food Industries
Key Takeaways: The Dual-Impact Proposition The FDA’s Review and Evaluation for Safe, Healthy, and Affordable Foods Act, or the FRESH Act bill, arrives at a precarious moment for food manufacturers. The scenario resulting from this is both rewarding and complicated. On the one hand, its unified national regulatory framework simplifies operations and growth for large […]
Vapor Lock: The Global Sulfur Supply Crisis 2026
The sulfur market was already witnessing the dual effect of several supply-side contractions and a rapid release of demand from the new energy sector. Now, in 2026, amid geopolitical conflicts, the global sulfur and sulfuric acid market is entering an era of uncertainty and long-term supply crunch. Export bans imposed by China, Turkey, and Russia, […]
Market Assessment and Capacity Planning for Pancreatic Cancer CDMO Entry
A global Contract Development and Manufacturing Organization (CDMO) sought Stellarix’s support to assess the strategic and financial viability of pancreatic cancer-focused manufacturing devices. Our strategic intelligence enabled demand-driven capacity planning and informed market entry through effective risk mitigation and clear market visibility. Client Background: A global Contract Development and Manufacturing Organization (CDMO) intended to evaluate […]